Table 2.
Demographic characteristics of the study patients with differences in EQ-5D and EQ-VAS (N = 75).
| Variables | N | EQ-5D score |
EQ-VAS score |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Median | IQR | p-Value | Mean | SD | Median | IQR | p-Value | ||
| Gendera | 0.001* | 0.03* | |||||||||
| Male | 58 | 0.74 | 0.20 | 0.72 | 0.13 | 70.2 | 17.5 | 70.0 | 20.0 | ||
| Female | 17 | 0.58 | 0.23 | 0.62 | 0.30 | 62.6 | 12.5 | 65.0 | 20.0 | ||
| Age, yearsb | 0.717 | 0.556 | |||||||||
| Less than 45 | 8 | 0.66 | 0.29 | 0.76 | 0.46 | 65.0 | 14.8 | 67.50 | 16.25 | ||
| 45–55 | 34 | 0.69 | 0.23 | 0.72 | 0.16 | 68.0 | 18.1 | 70.00 | 21.25 | ||
| 56–65 | 24 | 0.71 | 0.21 | 0.72 | 0.22 | 68.7 | 12.7 | 70.00 | 20.00 | ||
| More than 65 | 9 | 0.79 | 0.11 | 0.81 | 0.14 | 72.7 | 23.5 | 80.00 | 27.50 | ||
| Marital statusa | 0.219 | 0.068 | |||||||||
| Married | 69 | 0.72 | 0.21 | 0.72 | 0.19 | 69.3 | 16.9 | 70.00 | 20.00 | ||
| Not married | 6 | 0.54 | 0.32 | 0.67 | 0.66 | 59.2 | 12.0 | 62.50 | 22.50 | ||
| Educational levelb | 0.163 | 0.973 | |||||||||
| Primary | 14 | 0.62 | 0.23 | 0.70 | 0.18 | 68.5 | 13.6 | 70.00 | 22.50 | ||
| Intermediate | 6 | 0.63 | 0.31 | 0.69 | 0.31 | 67.5 | 14.7 | 70.00 | 21.25 | ||
| Secondary | 15 | 0.75 | 0.19 | 0.79 | 0.19 | 68.3 | 18.6 | 70.00 | 20.00 | ||
| University | 40 | 0.73 | 0.21 | 0.72 | 0.12 | 68.7 | 17.8 | 70.00 | 20.00 | ||
| Job typeb | 0.154 | 0.187 | |||||||||
| Governmental | 52 | 0.70 | 0.23 | 0.72 | 0.19 | 67.8 | 15.9 | 70.00 | 20.00 | ||
| Business | 10 | 0.80 | 0.14 | 0.85 | 0.18 | 76.0 | 15.0 | 75.00 | 22.50 | ||
| Unemployed | 13 | 0.64 | 0.20 | 0.72 | 0.15 | 65.3 | 20.7 | 65.00 | 30.00 | ||
| Duration of diabetes,b years | 0.943 | 0.317 | |||||||||
| 5 or less | 18 | 0.66 | 0.28 | 0.72 | 0.31 | 67.7 | 21.9 | 70.00 | 27.50 | ||
| 6–10 | 18 | 0.73 | 0.22 | 0.74 | 0.26 | 71.1 | 13.0 | 70.00 | 16.25 | ||
| 11–15 | 14 | 0.72 | 0.20 | 0.69 | 0.23 | 66.4 | 12.6 | 70.00 | 22.50 | ||
| 16–20 | 14 | 0.72 | 0.20 | 0.72 | 0.20 | 74.2 | 15.9 | 80.00 | 26.25 | ||
| More than 20 | 11 | 0.70 | 0.17 | 0.72 | 0.12 | 60.9 | 17.7 | 65.00 | 15.00 | ||
| Type of treatmentb | 0.072 | 0.864 | |||||||||
| Diet only | 3 | 0.81 | 0.15 | 0.72 | 0.00 | 65.0 | 8.6 | 70.00 | 0.00 | ||
| Oral | 44 | 0.75 | 0.20 | 0.76 | 0.12 | 68.6 | 18.7 | 70.00 | 20.00 | ||
| Insulin only | 5 | 0.68 | 0.04 | 0.69 | 0.08 | 70.0 | 10.0 | 70.00 | 20.00 | ||
| Oral and insulin | 23 | 0.62 | 0.26 | 0.69 | 0.17 | 68.4 | 15.4 | 70.00 | 30.00 | ||
EQ-5D: EuroQoL-5 dimension; SD: standard deviation; VAS: visual analogue scales; IQR: interquartile range; HRQoL: health-related quality of life.
The mean HRQoL score was 0.71 ± 0.22 with VAS score of 68.5 ± 16.8.
a
Mann–Whitney test.
b
Kruskal–Wallis test.
*
p < 0.05.